Italy’s Omega Pharma Srl has expanded its dietary supplements offering in its domestic market by acquiring Inpha Nutraceuticals for an undisclosed sum.
Active in the research, development and commercialization of nutraceuticals, Inpha’s portfolio is centered around the cardiology and neurology supplement categories
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?